Cha, Y., Kim, Y. J., Lee, S., Kim, T., Choi, S. H., Kim, D., . . . Heo, D. S. (2017). Post-bevacizumab Clinical Outcomes and the Impact of Early Discontinuation of Bevacizumab in Patients with Recurrent Malignant Glioma. Cancer Res Treat.
Stile di citazione ChicagoCha, Yongjun, et al. "Post-bevacizumab Clinical Outcomes and the Impact of Early Discontinuation of Bevacizumab in Patients With Recurrent Malignant Glioma." Cancer Res Treat 2017.
Citazione MLACha, Yongjun, et al. "Post-bevacizumab Clinical Outcomes and the Impact of Early Discontinuation of Bevacizumab in Patients With Recurrent Malignant Glioma." Cancer Res Treat 2017.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.